Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.12 -0.15 (-1.13%)
At close: Oct 22, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) Return on Sales [ROS] (2011 - 2015)

Updated

Eloxx Pharmaceuticals (ELOX) recorded Return on Sales [ROS] of -38.81% in FY2024.

Analysis

Eloxx Pharmaceuticals (ELOX) Return on Sales [ROS] (2011 - 2015) Analysis & Trends

Starting with FY2010, Eloxx Pharmaceuticals' Return on Sales [ROS] history includes 5 years.

  • The FY2024 figure is the highest annual Return on Sales [ROS] in data going back to FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,145.84 Bn 1,114.43 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 501.86 Bn 474.97 Bn 12.70 Bn 37.86%
4 Merck 356.87 Bn 311.24 Bn 12.21 Bn -3.52%
5 Novartis Ag 301.53 Bn 265.52 Bn 11.24 Bn 32.97%
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn 20.57%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 34.95%
8 Gilead Sciences 195.50 Bn 169.70 Bn 6.22 Bn -133.21%
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn 28.37%
10 Eloxx Pharmaceuticals 89.07 Mn 15.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 -6,201,918.66%
Mar 31, 2015 -611,353.46%
Dec 31, 2014 -1,080,112.76%
Sep 30, 2014 -290,509.36%
Jun 30, 2014 -135,790.88%
Sep 30, 2012 -3,239.13%
Jun 30, 2012 -3,193.41%
Mar 31, 2012 -4,705.64%
Dec 31, 2011 -728.07%
API Access

Eloxx Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELOX&period=max&api_key=YOUR_API_KEY